Skip to main content
. Author manuscript; available in PMC: 2019 Apr 29.
Published in final edited form as: Lancet. 2016 Dec 1;389(10080):1756–1770. doi: 10.1016/S0140-6736(16)32126-2

Figure 5. Suggested treatment approach algorithm for moderate to severe ulcerative colitis.

Figure 5

Based on Toronto Consensus and European Crohn’s and Colitis Organisation guidelines.114,118 5-ASA=5-aminosalicylic acid. IV=intravenous. DI=dose intensification.